In silico Study of Natural inhibitors for Human papillomavirus-18 E6 protein

Author:

Proboningrat Annise1,Kharisma Viol Dhea2,Muhammad Ansori Arif Nur1,Rahmawati Rinza3,Fadholly Amaq1,Ann Villar Posa Gabrielle4,Sudjarwo Sri Agus5,Abdul Rantam Fedik6,Budianto Achmad Agung7

Affiliation:

1. Doctoral Program in Veterinary Science, Faculty of Veterinary Medicine, Universitas Airlangga, 60115, Surabaya, Indonesia.

2. Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Brawijaya, 65145, Malang, Indonesia.

3. Department of Chemistry, Faculty of Health Sciences, Muhammadiyah University of Surabaya, 60113, Surabaya, Indonesia.

4. School of Environmental Science and Management, University of the Philippines Los Baños, Los Baños, Philippines.

5. Department of Pharmacology, Faculty of Veterinary Medicine, Universitas Airlangga, 60115, Surabaya, Indonesia.

6. Department of Microbiology, Faculty of Veterinary Medicine, Universitas Airlangga, 60115, Surabaya, Indonesia.

7. Department of Health, Faculty of Vocational Studies, Universitas Airlangga, 60115, Surabaya, Indonesia.

Abstract

Globally, the leading cause of death from cancer in women is infection with the human papillomavirus (HPV). This calls for imperative actions to explore anticancer drugs against this threatening viral infection, in which case, natural ingredients are presumed to be a promising source. Several studies show that plant-origin compounds such as allicin, apigenin, capsaicin, cyanidin, fisetin, genistein, laricitrin, naringenin, piperine, and syringetin have demonstrated therapeutic effects against several cancer types. In this study, the interaction mechanism of these compounds with HPV-18 E6 oncoprotein, that is known to downregulate tumor suppressor p53, was predicted using an in silico approach. Molecular docking simulations of natural ligands and E6 protein were performe, followed by chemical interaction analysis and 3D molecular visualization. Results indicated that fisetin is the best natural inhibitor as it has the lowest binding energy. It is highly recommended that the results of this study be used as a reference in designing anticancer drugs in vitro and in vivo.

Publisher

A and V Publications

Subject

Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3